Osaic Holdings
CHRS icon

Osaic Holdings’s Coherus Oncology CHRS Stock Holding History

Osaic Holdings’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45K Sell
1,038
-500
-33% -$816 ﹤0.01% 7374
2026
Q1 		$2.6K Sell
1,538
-137
-8% -$243 ﹤0.01% 6952
2025
Q4 		$2.38K Sell
1,675
-169
-9% -$246 ﹤0.01% 7036
2025
Q3 		$2.38K Buy
1,844
+861
+88% +$958 ﹤0.01% 7088
2025
Q2 		$717 Sell
983
-1,635
-62% -$1.41K ﹤0.01% 7264
2025
Q1 		$2.11K Sell
2,618
-1,076
-29% -$1.24K ﹤0.01% 6570
2024
Q4 		$5.09K Sell
3,694
-78
-2% -$88 ﹤0.01% 6184
2024
Q3 		$3.92K Hold
3,772
– – ﹤0.01% 6318
2024
Q2 		$6.46K Sell
3,772
-182
-5% -$366 ﹤0.01% 6038
2024
Q1 		$9.43K Buy
3,954
+564
+17% +$1.39K ﹤0.01% 5770
2023
Q4 		$11.3K Sell
3,390
-425
-11% -$1.14K ﹤0.01% 5774
2023
Q3 		$14.3K Buy
3,815
+2,005
+111% +$9.26K ﹤0.01% 5731
2023
Q2 		$7.73K Hold
1,810
– – ﹤0.01% 6092
2023
Q1 		$12.4K Hold
1,810
– – ﹤0.01% 5850
2022
Q4 		$14.5K Buy
1,810
+1,726
+2,055% +$13.3K ﹤0.01% 5757
2022
Q3 		$1K Hold
84
– – ﹤0.01% 6953
2022
Q2 		$1K Sell
84
-487
-85% -$4.24K ﹤0.01% 7044
2022
Q1 		$8K Sell
571
-966
-63% -$12.3K ﹤0.01% 6257
2021
Q4 		$24K Buy
1,537
+419
+37% +$7.33K ﹤0.01% 5662
2021
Q3 		$17K Buy
1,118
+373
+50% +$5.47K ﹤0.01% 5874
2021
Q2 		$10K Buy
745
+306
+70% +$4.33K ﹤0.01% 6047
2021
Q1 		$6K Buy
439
+236
+116% +$4.01K ﹤0.01% 6067
2020
Q4 		$4K Sell
203
-842
-81% -$15K ﹤0.01% 5832
2020
Q3 		$19K Buy
1,045
+500
+92% +$9.3K ﹤0.01% 4931
2020
Q2 		$10K Sell
545
-4,620
-89% -$78.2K ﹤0.01% 5166
2020
Q1 		$82K Buy
+5,165
New +$95.4K ﹤0.01% 3620

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $510M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Osaic Holdings's CHRS Position: Q2 2026 in Review

Osaic Holdings reduced its Coherus Oncology (CHRS) stake by 33% in Q2 2026, selling an estimated $816 and leaving 1,038 shares worth $1.45K. The position accounts for ﹤0.01% of the portfolio, ranked #7374.

Osaic Holdings first reported a position in CHRS in Q1 2020 and has held it in 26 quarters since. The position peaked at $82K in Q1 2020. 147 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • Osaic Holdings held 1,038 shares of Coherus Oncology worth $1.45K as of Q2 2026.
  • Osaic Holdings sold 500 Coherus Oncology shares in Q2 2026, an estimated $816.
  • Coherus Oncology made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7374 holding.
  • Osaic Holdings first reported a position in Coherus Oncology in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Coherus Oncology position peaked at $82K in Q1 2020.
  • 147 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.